• ქართული
  • English
  • Starboard to vote against Celgene/Bristol deal, move ahead with proxy

    Activist investor Starboard Value LP plans to vote against Bristol-Myers Squibb Co’s proposed $74 billion takeover of biotech Celgene Corp and urged other shareholders to join it in voting down the “poorly conceived and ill-advised” deal.

    Market Quotes by TradingView